Top KHN Original Stories

View More

Total Results: 230

Sanofi Claims Mylan Artificially Bumped Up EpiPen Prices, Then Undercut Competition With Rebates

KHN Morning Briefing

The drugmaker filed a lawsuit against the troubled EpiPen-maker on Monday. In other pharmaceutical news, The Daily Beast investigates the involvement of Rep. Chris Collins, R-N.Y., with an Australian biotech company, a panel of U.S. scientists is questioning the methodology of an Ebola drug trial, Biogen releases the promising results of a drug to help children with a neuromuscular disease, and one California lawmaker has a plan for lowering drug prices.